Cell Banking Outsourcing Market Worth $9.87 Billion By 2022: Grand View Research, Inc.

News provided by

Grand View Research, Inc.

21 Oct, 2015, 13:15 BST

SAN FRANCISCO, October 21, 2015 /PRNewswire/ --

The global cell banking outsourcing market is expected to reach USD 9.87 billion by 2022, according to a new report by Grand View Research, Inc. Factors attributing towards this anticipated market size include growing demand for gene therapy, stem cell therapy, biopharmaceutical production that target on novel active sites.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757)

Browse full research report with TOC on "Cell Banking Outsourcing Market Analysis By Bank Type (Master Cell Banks, Working Cell Banks, Viral Cell Banks), By Cell Type (Stem Cell, Cord Blood, Embryonic, Adult Stem, Dental, IPS Stem Cells, Non-stem Cells), By Phase (Bank Preparation, Storage, Characterization & Testing, Safety Testing, Viral, Microbial Banks, Gene Expression, Karyology, Gene Sequencing Testing) And Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/cell-banking-outsourcing-market                                                                                      

Additionally, rise in prevalence of oncology associated diseases and other infectious chronic disorders are expected to promote cytological R&D in which cell banking plays a pivotal role thereby driving growth. R&D for commercialization of novel characterization and cryopreservation methods is also expected to considerably enhance lucrative growth opportunities over the forecast period.

Further key findings from the report suggest: 

  • Master cell banks accounted for over 60% of revenue generated in 2014 owing to rise in these facilities across the globe. Moreover, master cell banks are useful for the preparation of working cell banks and thus find applicability in various research and development perspectives for stem cell therapy and gene therapy thereby resulting to segment growth.
  • Stem cells accounted for the largest share with respect to revenue in cell banking market by cell type. Factors attributive towards large share of this segment include availability of stem cells from different organ origins and there consequent use in different metabolic disorders.
  • North America accounted for the largest share of this market for 2014, as there are a significantly high number of research and development projects ongoing in the region related to cytological investigation for proteomics, genomics, and drug and vaccine development. Growing need for vaccines and biopharmaceuticals is also anticipated to fuel the growth of this region.
  • Asia Pacific is expected to witness significant growth in demand over the forecast period owing to increase in number of supportive government initiatives pertaining to investments in biotechnology sector. Additionally, ongoing R&D activities for cancer treatment and fertility preservation facilitate the demand for cell banking services.
  • Key participants in the cell banking outsourcing market include BioReliance, BioOutsource (Sartorious), BSL Bioservice, Cleancells, Charles River Laboratories, Covance, GlobalStem Inc., Lonza, PX'Therapeutics SA, SGS Life Sciences, Texcell, Toxikon Corporation, Wuxi Apptec, Reliance Life Sciences, LifeCell International Pvt. Ltd., Cryobanks International India, Cryo-Cell International Inc., and CordLife.
  • Market participants are involved in R&D for characterization of cell banks which include introduction of efficient gene sequencing tests, karyology, and safety tests.

Grand View Research has segmented cell banking outsourcing market on the basis of bank type, cell type, phase of development of cell bank, and region:

  • Cell Banking Outsourcing Outlook, by Bank Type (Revenue, USD Million, 2012 - 2022 ) 
    • Master Cell Banking
    • Working Cell Banking
    • Viral Cell Banking
  • Cell Banking Outsourcing Outlook, by Cell Type (Revenue, USD Million, 2012 - 2022 ) 
    • Stem Cell Banking
      • Cord Stem Cell Banking
      • Embryonic Stem Cell Banking
      • Adult Stem Cell Banking
      • Dental Stem Cell Banking
      • IPS Stem Cell Banking
    • Non-stem Cell Banking
  • Cell Banking Outsourcing Phase Outlook (Revenue, USD Million, 2012 - 2022 ) 
    • Cell Bank Storage
      • Master Cell Bank Storage
      • Working Cell Bank Storage
      • Cell Storage Stability Testing
    • Bank Characterization and Testing
      • Safety Testing
        • Viral Cell Bank Safety Testing
        • Microbial Cell Bank Safety Testing
        • Gene Expression Testing
        • Karyology Testing
        • Gene Sequencing Testing
    • Cell Bank Preparation
      • Master Cell Bank Preparation
      • Working Cell Bank Preparation
  • Cell Banking Outsourcing Regional Outlook (Revenue, USD Million, 2012 - 2022) 
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • UK
    • Asia Pacific
      • Japan
      • China
      • India
      • Korea
      • Singapore
    • Latin America
      • Brazil
      • Mexico
    • MEA
      • South Africa

Browse related reports by Grand View Research: 

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Read Our Blogs - dniamericas.org, ni2014.org  

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com

Web: http://www.grandviewresearch.com  

SOURCE Grand View Research, Inc.